Patanjali Case: Court Asks Ramdev, Balkrishna To Appear On Aug 6

Kozhikode: The case relating to ‘misleading’ advertisements of Patanjali Ayurved’s products in the media will be heard on August 6.

The Kozhikode court on Monday issued summons to Yoga guru Ramdev and his associate Acharya Balkrishna to appear before the court on this date. The order comes after the two failed to appear before the court today as directed earlier. The summons order was issued by the Kozhikode Judicial First Class Magistrate Court.

Ramdev, founder is the second accused in the case and Balkrishna is the third accused. The marketing wing of Patanjali Ayurved, Divya Pharmacy, is the first accused.

The Office of the Assistant Drugs Controller, Kozhikode lodged a complaint based on which a case was registered under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 in April.

In February, the Supreme Court had issued a contempt notice against Patanjali Ayurved and restrained it from publishing advertisements of medicines used for treatment of ailments including blood pressure, asthma, arthritis and obesity.

The first complaint against Divya Pharmacy was filed in February 2022 by KV Babu, an ophthalmologist from Kannur. He had lodged a complaint at the State Drug Control Department. Following which, the State Drug Control Department had ordered an inquiry and instances of violation of the Act surfaced.

Related Posts

  • Pharma
  • May 17, 2025
  • 13 views
Singapore May Avoid US Pharma Tariffs: Deputy PM

Singapore: Singapore may be able to escape tariffs on pharmaceutical exports to the United States even if Washington goes ahead with plans to introduce the sectoral tariff, Deputy Prime Minister…

  • Pharma
  • May 17, 2025
  • 46 views
Fire disrupts production at GSK Pharma’s contract manufacturing site

GlaxoSmithKline Pharmaceuticals (GSK Pharma) on Friday informed the stock exchanges that a fire had occurred at one of its contract manufacturing facilities, causing a temporary disruption in production at the…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Singapore May Avoid US Pharma Tariffs: Deputy PM

Singapore May Avoid US Pharma Tariffs: Deputy PM

Fire disrupts production at GSK Pharma’s contract manufacturing site

Fire disrupts production at GSK Pharma’s contract manufacturing site

Trump targets Big Pharma with drug price order; Indian generics seen gaining edge

Trump targets Big Pharma with drug price order; Indian generics seen gaining edge

Emcutix and Mantra Pharma Introduce Ureaderm: Advanced Urea-Based Moisturizers for Indian Skin

Emcutix and Mantra Pharma Introduce Ureaderm: Advanced Urea-Based Moisturizers for Indian Skin

DCA seizes syrup stocks over misleading fever cure claim

DCA seizes syrup stocks over misleading fever cure claim

Mankind Pharma Faces Rs 341.86 Cr Tax Demand

Mankind Pharma Faces Rs 341.86 Cr Tax Demand